C-terminal truncation of GSK-3β enhances its dephosphorylation by PP2A
1Key laboratory of neuroregeneration of Jiangsu and Ministry of Education, Co-innovation Center of Regeneration, Nantong University, China.
Abstract:
Glycogen synthase kinase-3β (GSK-3β) is the major tau kinase. Its phosphorylation at Ser9 suppresses the activity. In Alzheimer's disease (AD) brain, GSK-3β is truncated at the C terminus by overactivated calpain I, leading to an increase in its activity. However, the effect of truncation on its phosphorylation is unknown. We found here that in AD brain and in cultured cells, C-terminally truncated GSK-3β is less phosphorylated at Ser9 than the full-length enzyme. The truncation promotes GSK-3β nuclear translocation and enhances its interaction with protein phosphatase 2A (PP2A), leading to dephosphorylation. Thus, the truncation of GSK-3β may enhance its activity through Ser9 dephosphorylation by PP2A. Our findings shed new light on the role of calpain-GSK-3β-PP2A in tau pathogenesis of AD.
Insights
Truncation of glycogen synthase kinase-3β (GSK-3β) by calpain I in Alzheimer's disease (AD) brains reduces its Ser9 phosphorylation. This dephosphorylation enhances GSK-3β activity, potentially contributing to tau pathology.
Area of Science:
- Neuroscience
- Biochemistry
- Pathology
Background:
- Glycogen synthase kinase-3β (GSK-3β) is a key enzyme in tau protein phosphorylation.
- In Alzheimer's disease (AD), GSK-3β is truncated by calpain I, increasing its activity.
- The impact of this truncation on GSK-3β phosphorylation remains unclear.
Purpose of the Study:
- To investigate the effect of C-terminal truncation on GSK-3β phosphorylation at Ser9.
- To elucidate the mechanism by which truncated GSK-3β activity is regulated in AD.
- To explore the role of the calpain-GSK-3β-protein phosphatase 2A (PP2A) pathway in AD tau pathogenesis.
Main Methods:
- Analysis of GSK-3β phosphorylation at Ser9 in AD brain samples and cultured cells.
- Investigation of GSK-3β nuclear translocation and interaction with PP2A.
- Assessment of the impact of C-terminal truncation on GSK-3β activity and PP2A-mediated dephosphorylation.
Main Results:
- C-terminally truncated GSK-3β exhibits reduced Ser9 phosphorylation compared to full-length GSK-3β in AD brains and cell cultures.
- Truncation facilitates GSK-3β nuclear translocation and enhances its binding to PP2A.
- PP2A-mediated dephosphorylation of truncated GSK-3β leads to increased enzyme activity.
Conclusions:
- GSK-3β truncation by calpain I in AD brains results in decreased Ser9 phosphorylation.
- This dephosphorylation, mediated by enhanced PP2A interaction, likely contributes to increased GSK-3β activity.
- The calpain-GSK-3β-PP2A axis represents a significant pathway in the tau pathology of Alzheimer's disease.
More Related Videos
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
10:08Study of the Functions and Activities of Neuronal K-Cl Co-Transporter KCC2 Using Western Blotting
Published on: December 9, 2022
Related Concept Videos
Amplifying Signals via Enzymatic Cascade
GPCR Desensitization
PI3K/mTOR/AKT Signaling Pathway
GPCRs Regulate Adenylyl Cylase Activity
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Anaphase Promoting Complex
